NCOA6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.615400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.706000E-01
Normal-vs-Stage2
8.726200E-01
Normal-vs-Stage3
1.215180E-01
Normal-vs-Stage4
3.342200E-01
Stage1-vs-Stage2
8.045800E-01
Stage1-vs-Stage3
1.554240E-02
Stage1-vs-Stage4
3.542400E-01
Stage2-vs-Stage3
4.395800E-02
Stage2-vs-Stage4
1.125980E-01
Stage3-vs-Stage4
5.455700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.870800E-01
Normal-vs-AfricanAmerican
5.381200E-01
Normal-vs-Asian
9.612200E-01
Caucasian-vs-AfricanAmerican
4.519400E-01
Caucasian-vs-Asian
7.172400E-01
AfricanAmerican-vs-Asian
4.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.083800E-01
Normal-vs-Female
9.464000E-01
Male-vs-Female
4.631000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.450400E-01
Normal-vs-Age(41-60Yrs)
4.092400E-01
Normal-vs-Age(61-80Yrs)
9.133200E-01
Normal-vs-Age(81-100Yrs)
6.931400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.823000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.050800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.093800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.299970E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.577900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.921000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.513000E-01
Normal-vs-Daily Drinker
8.653000E-01
Normal-vs-Weekly Drinker
8.507000E-01
Normal-vs-Occasional Drinker
4.104400E-01
Normal-vs-Social Drinker
6.213000E-01
Non Drinker-vs-Daily Drinker
8.274600E-01
Non Drinker-vs-Weekly Drinker
8.062400E-01
Non Drinker-vs-Occasional Drinker
2.236400E-02
Non Drinker-vs-Social Drinker
1.074610E-01
Daily Drinker-vs-Weekly Drinker
9.757200E-01
Daily Drinker-vs-Occasional Drinker
7.611700E-02
Daily Drinker-vs-Social Drinker
2.251400E-01
Weekly Drinker-vs-Occasional Drinker
8.380100E-02
Weekly Drinker-vs-Social Drinker
2.482800E-01
Occasional Drinker-vs-Social Drinker
7.126400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.891800E-01
Normal-vs-Grade 2
7.922000E-02
Normal-vs-Grade 3
4.581900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.418400E-01
Grade 1-vs-Grade 3
3.916400E-01
Grade 1-vs-Grade 4
2.891800E-01
Grade 2-vs-Grade 3
2.348200E-01
Grade 2-vs-Grade 4
7.922000E-02
Grade 3-vs-Grade 4
4.581900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.680600E-01
Normal-vs-NonDiabetic
7.964400E-01
Diabetic-vs-NonDiabetic
4.217800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.729600E-01
Normal-vs-NoPancreatitis
9.319600E-01
Pancreatitis-vs-NoPancreatitis
6.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.963200E-01
Normal-vs-N1
8.554600E-01
N0-vs-N1
9.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.910200E-01
Normal-vs-TP53-NonMutant
7.187200E-01
TP53-Mutant-vs-TP53-NonMutant
2.378600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
